중환자실 획득 근력 쇠약

키워드

참고문헌 (43)

1. MacFarlane IA, "Severe myopathy after status asthmaticus", Lancet, 2, pp.615~ (1977)
2. Bolton CF, "Polyneuropathy in critically ill patients", J Neurol Neurosurg Psychiatry, 47, pp.1223~1231 (1984)
3. Latronico N, "Critical illness myopathy and neuropathy", Lancet, 347, pp.1579~1582 (1996)
4. Stevens RD, "Neuromuscular dysfunction acquired in critical illness: a systemic review", Intensive Care Med, 33, pp.1876~1891 (2007)
5. Witt N, "Peripheral nerve function in sepsis and multiple organ failure", Chest, 99, pp.176~184 (1991)
6. Van den Berghe G, "Insulin therapy protects the central and peripheral nervous system of intensive care patients", Neurology, 64, pp.1348~1353 (2005)
7. De Jonghe B, "Paresis acquired in the intensive care unit: a prospective multicenter study", JAMA, 288, pp.2859~2867 (2002)
8. Eikermann M, "Muscle force and fatigue in patients with sepsis and multiorgan failue", Intensive Care Med, 32, pp.251~259 (2006)
9. Ochala J, "Factors underlying the early limb muscle weakness in acute quadriplegic myopathy using an experimental ICU porcine model", LOoD One, 6, pp.e20876~ (2011)
10. Larsson L, "Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanism at the cellular and molecular levels", Crit Care Med, 28, pp.34~45 (2000)
11. Rich MM, "Muscle is electrically inexcitable in acute quadriplegic myopathy", Neurology, 46, pp.731~736 (1996)
12. Rich MM, "Direct muscle stimulation in acute quadriplegic myopathy", Muscle Nerve, 20, pp.665~673 (1997)
13. Teener JW, "Dysregulation of sodium channel gating in critical illness myopathy", J Muscle Res Cell Motil, 27, pp.291~296 (2006)
14. Rich MM, "Loss of electrical excitability in an animal model of acute quadriplegic myopathy", Ann Neurol, 43, pp.171~179 (1998)
15. Rich MM, "Sodium channel inactivation in an animal model of acute quadriplegic myopathy", Ann Neurol, 50, pp.26~33 (2001)
16. Rich MM, "Crucial role of sodium channel fast inactivation in muscle fiber inexcitability in a rat model of critical illness myopathy", J Physiol, 547, pp.555~566 (2003)
17. Berg DK, "Increased extrajunctional acetycholine sensitivity produced by chronic post-synaptic neuromuscular blockade", J Physiol, 244, pp.659~676 (1975)
18. Filatov GN, "Hyperpolarized shifts in the voltage dependence of fast inactivation of Nav1.4 and Nav1.5 in a rat model of critical illness neuropathy", J Physiol, 559, pp.813~820 (2004)
19. Rich MM, "ECG changes during septic shock", Cardiology, 97, pp.187~196 (2002)
20. Bolton CF, "Neuromuscular manifestations of critical illness", Muscle Nerve, 32, pp.140~163 (2005)
21. Otto A, "Signalling and control of skeletal muscle size", Exp Cell Res, 316, pp.3059~3066 (2010)
22. Bodine SC, "Akt", mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo, 2001, pp.3, 1014~1019
23. Lang CH, "Role of growth hormone, insulin-like growth factor-1, and insulin-like growth factor binding proteins in catabolic response to injury and infection", Curr Opin Clin Nutr Metab Care, 5, pp.271~279 (2002)
24. Lin MC, "Down-regulation of insulin-like growth factor 1(IGF-1) in the mouse diaphragm during sepsis", Chang Gung Med J, 33, pp.501~508 (2010)
25. Lecker SH, "Muscle protein breakdown and the critical role of the ubiquitinproteasome pathway in normal and disease states", J Nutr, 129(supp), pp.s227~s237 (1999)
26. Jackman RW, "The molecular basis of skeletal muscle atrophy", Am J Physiol Cell Physiol, 287, pp.834~843 (2004)
27. Cai D, "IKKB", NF-kB activation causes severe muscle wasting in mice, 2004, pp.119, 285~298
28. Leger B, "Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1", FASEB J, 20, pp.583~585 (2006)
29. Waddel DS, "The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF-1 gene", Am J Physiol Endocrinol Metab, 295, pp.E785~E797 (2008)
30. Stevens RD, "A framework for diagnosing and classifying intensive care unit-acquired weakness", Crit Care Med, 37, pp.s299~s308 (2009)
31. Kleyweg RP, "Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome", Muscle Nerve, 14, pp.1103~1109 (1991)
32. Hough CL, "Intensive care unit-acquired neuropathy and corticosteroids in survivors of persistent ARDS", Intensive Care Med, 35, pp.63~68 (2009)
33. Maramattom BV, "Acute neuromuscular weakness in the intensive care unit", Crit Care Med, 34, pp.2835~2841 (2006)
34. Rich MM, "Direct muscle stimulation in acute quadriplegic myopathy", Muscle Nerve, 20, pp.665~673 (1997)
35. Dhand UK, "Clinical approach to the weak patient in the intensive care unit", Respiratory Care, 51, pp.1024~1040 (2006)
36. Pati S, "Approach to critical illness polyneuropathy and myopathy", Postgrad Med J, 84, pp.354~360 (2008)
37. Bolton CF, "Critically ill polyneuropathy: Electrophysiological studies and differentiation from Guillain-Barre syndrome", J Neurol Neurosurg Psychiatry, 49, pp.563~573 (1986)
38. Krendel DA, "Hypermagnesemia and neuromuscular transmission", Semin Neurol, 10, pp.42~45 (1990)
39. Liu YC, "Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis", Am J Med Sci, 327, pp.264~267 (2004)
40. Vincent JL, "Intensive care unit-acquired weakness: Framing the topic", Crit Care Med, 37(supp), pp.s296~s298 (2009)
41. Van Den Berghe G, "Intensive insulin therapy in the medical ICU", NEJM, 354, pp.449~461 (2006)
42. Van Den Berghe G, "Intensive insulin therap y in critically ill patients", NEJM, 345, pp.1359~1367 (2001)
43. Deem S, "Acquired neuromuscular disorders in the intensive care unit", Am J Respir Crit Care Med, 168, pp.735~739 (2003)

관련 논문AI추천